Morning Seminar Vol 3(3) September 2005
Prediction of MYCN amplification in NB; Using serum DNA and real-time quantitative PCR (Gotoh, JCO 2005) 159
The 7th international childhood ALL workshop report: Palermo, Italy, January 29-30, 2005 (Arico, Leukemia 2005) 161
Pain relief for patients with pediatric cancer 165
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic SCT, and prophylactic donor lymphocyte transfusion in high-risk AML and MDS (Schmid, JCO 2005) 170
Allogeneic BMT in children with MDS or JMML: the Seattle experience (Yusuf, BMT 2004) 176
Central venous catheter infection 179
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults (Oxman, N Engl J Med 2005) 187
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French society of pediatric oncology study (Oyharcabal-Bourden, JCO 2005) 192
Antibacterial prophylaxis after cancer chemotherapy for solid tumors and lymphomas (Cullen, N Engl J Med 2005) 196
Phase I and pharmacokinetic study of Gefitinib in children with refractory solid tumors: a COG study (Daw, JCO 2005) 202
Group III & IV rhabdomyosarcoma 206
European Intergroup Studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (Carli, JCO 2004) 207
Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients (Heemskerk, J Infect Dis 2005) 213
Evidence for an age cutoff greater than 365 days for NB risk group stratification in the Children’s Oncology Group (London, JCO 2005) 218
Review of alveolar soft part sarcoma (ASPS) 222
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence:Third Study of the International Society of Paediatric Oncology – SIOP Malignant Mesenchymal Tumor 89 (Stevens, JCO 2005) 225
Oncolytic viral therapies (Lin, Cancer Gene Therapy 2004) 233
Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children (Ikarashi, Pedistr Int 2004) 239
The 7th international childhood ALL workshop report: Palermo, Italy, January 29-30, 2005 (Arico, Leukemia 2005) 161
Pain relief for patients with pediatric cancer 165
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic SCT, and prophylactic donor lymphocyte transfusion in high-risk AML and MDS (Schmid, JCO 2005) 170
Allogeneic BMT in children with MDS or JMML: the Seattle experience (Yusuf, BMT 2004) 176
Central venous catheter infection 179
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults (Oxman, N Engl J Med 2005) 187
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French society of pediatric oncology study (Oyharcabal-Bourden, JCO 2005) 192
Antibacterial prophylaxis after cancer chemotherapy for solid tumors and lymphomas (Cullen, N Engl J Med 2005) 196
Phase I and pharmacokinetic study of Gefitinib in children with refractory solid tumors: a COG study (Daw, JCO 2005) 202
Group III & IV rhabdomyosarcoma 206
European Intergroup Studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors (Carli, JCO 2004) 207
Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients (Heemskerk, J Infect Dis 2005) 213
Evidence for an age cutoff greater than 365 days for NB risk group stratification in the Children’s Oncology Group (London, JCO 2005) 218
Review of alveolar soft part sarcoma (ASPS) 222
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence:Third Study of the International Society of Paediatric Oncology – SIOP Malignant Mesenchymal Tumor 89 (Stevens, JCO 2005) 225
Oncolytic viral therapies (Lin, Cancer Gene Therapy 2004) 233
Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children (Ikarashi, Pedistr Int 2004) 239
posted by hohtaped @ 9:47 AM
<< Home